Drug intelligence / Profile preview

Prolact+ H2MF

Development stage
Unknown
Lead developer
Prolacta Bioscience
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Prolact+ H2MF is a human milk-based human milk fortifier (HMBF) developed by Prolacta Bioscience, specifically designed for the nutritional management of extremely preterm infants (typically those born weighing less than 1,250 grams). It is the first commercially available fortifier derived entirely from pasteurized donor human milk, providing concentrated protein, calories, and minerals to support growth while allowing the infant to remain on an exclusive human milk diet (EHMD). The product is used to avoid the potential complications associated with bovine milk-based fortifiers (BMBF), such as necrotizing enterocolitis (NEC) and late-onset sepsis. While early observational data suggested significant clinical benefits, recent large-scale randomized controlled trials, including the N-HMBF study in Sweden, have shown that H2MF may not significantly reduce the composite incidence of NEC, sepsis, or mortality when compared to bovine-based fortifiers in infants already receiving an exclusive human milk diet.

Brand names
Prolact+ H2MFProlact+ H2MF 4Prolact+ H2MF 6Prolact+ H2MF 8Prolact+ H2MF 10
Other names
human milk-based human milk fortifierHMBFhuman milk-based fortifier

Beyond the preview

Go deeper on Prolact+ H2MF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prolact+ H2MF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call